Yun Xia Yang
Direktor/Vorstandsmitglied bei CUTIA THERAPEUTICS
Aktive Positionen von Yun Xia Yang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CUTIA THERAPEUTICS | Direktor/Vorstandsmitglied | 26.08.2020 | - |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Direktor/Vorstandsmitglied | 31.08.2020 | - |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Direktor/Vorstandsmitglied | - | - |
AccuMedical Beijing Co., Ltd.
AccuMedical Beijing Co., Ltd. Medical SpecialtiesHealth Technology AccuMedical Beijing Ltd. engages in developing and manufacturing medical devices. Its products include flow re-direction system, microcatheter and distal access catheter. The company was founded by Yi Ran Lu on August 29 , 2017 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 09.06.2022 | - |
Jiutian Biopharmaceutical (Shanghai) Co., Ltd.
Jiutian Biopharmaceutical (Shanghai) Co., Ltd. BiotechnologyHealth Technology Jiutian Biopharmaceutical (Shanghai) Co., Ltd. is a Chinese biotechnology company founded in 2019. The company operates in the field of biotechnology and is based in Shanghai, CN. It is worth noting that the company has subsidiaries in Cayman Islands and United States. | Direktor/Vorstandsmitglied | - | - |
Qianglian Zhichuang (Beijing) Technology Co., Ltd.
Qianglian Zhichuang (Beijing) Technology Co., Ltd. Hospital/Nursing ManagementHealth Services Qianglian Zhichuang (Beijing) Technology Co., Ltd. is a Chinese company that focuses on stroke diagnosis and treatment. The company is based in Beijing, China. The company offers integrated intelligent diagnosis and treatment services for bleeding and ischemic stroke. Qianglian Zhichuang® has developed a one-stop stroke intelligence diagnosis and treatment platform that covers prevention, screening, diagnosis, treatment, rehabilitation, and long-term follow-up. The company collaborates with leading domestic neural clinical centers, including Xuanwu Hospital, Huashan Hospital of Tiantan Hospital, and Changhai Hospital. Qianglian Zhichuang® has applied for dozens of national and provincial research topics and has applied for related fields of hundreds of domestic and international patents. The company was founded in 2016 by Lan Qin, Wen Zhe Liu. Wen Zhe Liu has been the CEO since 2016. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Yun Xia Yang
Ehemalige bekannte Positionen von Yun Xia Yang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BURNING ROCK BIOTECH LIMITED | Direktor/Vorstandsmitglied | 01.01.2017 | 14.07.2022 |
ADAGENE INC. | Direktor/Vorstandsmitglied | 01.06.2019 | 08.02.2021 |
Legend Capital Co. Ltd.
Legend Capital Co. Ltd. Investment ManagersFinance Legend Capital Co. Ltd (Legend Capital) is a private equity venture capital subsidiary of Legend Holdings Corp. founded in 2001 by Zhu Li Nan. The firm is headquartered in Beijing, China. | Corporate Officer/Principal | 01.04.2011 | 01.05.2015 |
░░░░░░░ ░ ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Yun Xia Yang
Duke University | Masters Business Admin |
Huazhong University of Science & Technology | Graduate Degree |
Tongji Medical College of Huazhong University of Sci & Tech | Graduate Degree |
Statistik
International
China | 14 |
Vereinigte Staaten | 2 |
Hong Kong | 2 |
Operativ
Director/Board Member | 8 |
Corporate Officer/Principal | 4 |
Graduate Degree | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ADAGENE INC. | Health Technology |
BURNING ROCK BIOTECH LIMITED | Health Services |
CUTIA THERAPEUTICS | Health Technology |
Private Unternehmen | 9 |
---|---|
Legend Capital Co. Ltd.
Legend Capital Co. Ltd. Investment ManagersFinance Legend Capital Co. Ltd (Legend Capital) is a private equity venture capital subsidiary of Legend Holdings Corp. founded in 2001 by Zhu Li Nan. The firm is headquartered in Beijing, China. | Finance |
GE Healthcare (China) Co. Ltd. | |
Johnson & Johnson China Ltd.
Johnson & Johnson China Ltd. Pharmaceuticals: MajorHealth Technology Part of Kenvue, Inc., Johnson & Johnson China Ltd. is a Chinese company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Health Technology |
Sequoia Capital China Investment Management LP
Sequoia Capital China Investment Management LP Financial ConglomeratesFinance Part of Al Nawwar Investments RSC Ltd., Sequoia Capital China Investment Management LP operates as an investment holding Chinese company. | Finance |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Commercial Services |
AccuMedical Beijing Co., Ltd.
AccuMedical Beijing Co., Ltd. Medical SpecialtiesHealth Technology AccuMedical Beijing Ltd. engages in developing and manufacturing medical devices. Its products include flow re-direction system, microcatheter and distal access catheter. The company was founded by Yi Ran Lu on August 29 , 2017 and is headquartered in Beijing, China. | Health Technology |
Qianglian Zhichuang (Beijing) Technology Co., Ltd.
Qianglian Zhichuang (Beijing) Technology Co., Ltd. Hospital/Nursing ManagementHealth Services Qianglian Zhichuang (Beijing) Technology Co., Ltd. is a Chinese company that focuses on stroke diagnosis and treatment. The company is based in Beijing, China. The company offers integrated intelligent diagnosis and treatment services for bleeding and ischemic stroke. Qianglian Zhichuang® has developed a one-stop stroke intelligence diagnosis and treatment platform that covers prevention, screening, diagnosis, treatment, rehabilitation, and long-term follow-up. The company collaborates with leading domestic neural clinical centers, including Xuanwu Hospital, Huashan Hospital of Tiantan Hospital, and Changhai Hospital. Qianglian Zhichuang® has applied for dozens of national and provincial research topics and has applied for related fields of hundreds of domestic and international patents. The company was founded in 2016 by Lan Qin, Wen Zhe Liu. Wen Zhe Liu has been the CEO since 2016. | Health Services |
Jiutian Biopharmaceutical (Shanghai) Co., Ltd.
Jiutian Biopharmaceutical (Shanghai) Co., Ltd. BiotechnologyHealth Technology Jiutian Biopharmaceutical (Shanghai) Co., Ltd. is a Chinese biotechnology company founded in 2019. The company operates in the field of biotechnology and is based in Shanghai, CN. It is worth noting that the company has subsidiaries in Cayman Islands and United States. | Health Technology |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Health Technology |
- Börse
- Insiders
- Yun Xia Yang
- Erfahrung